KIN1148 T4027
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
KIN1148 is a novel small-molecule adjuvant that acts through the RIG-I pathway and IRF-3 transcription factor to stimulate inN/Ate immunity and protection following viral infection. The adjuvant will be developed for an FDA-approved avian inluenza virus v
CAS nr:
1428729-56-9
Purity:
98%
Molecular Weight:
361,44
SMILES:
O=C(Nc1nc2ccc3scnc3c2s1)c1ccc2ccccc2c1
Formula:
C19H11N3OS2
Pathway:
Microbiology/Virology
Target:
Influenza Virus
